Person

Albert Bourla

Chairman & CEO · Director, Pfizer

Current S&P 500 boards
1
Current roles
1
Open-market buys
$1.0M
Open-market sales
$6.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

  • PFE
    Pfizer
    DirectorChairman & CEO
    since 2016 or earlier

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 12, 2026PFEBuy38,000$26.34$1.0M
Nov 9, 2020PFESale132,508$41.94$5.6M
Nov 4, 2016PFESale5,707$30.04$171K
Nov 4, 2016PFESale1,690$30.03$51K
Nov 4, 2016PFESale100$30.06$3K
Nov 4, 2016PFESale10,893$30.05$327K

SEC reporting-owner ID (CIK) 1595703 · all filings on EDGAR

Albert Bourla (PFE) | USBoard